[1]
|
Nicolaides, A., Kakkos, S., Baekgaard, N., et al. (2018) Management of Chronic Venous Disorders of the Lower Limbs. Guidelines According to Scientific Evidence. Part I. International Angiology, 37, 181-254.
https://doi.org/10.23736/S0392-9590.18.03999-8
|
[2]
|
中国中西医结合学会大肠肛门病专业委员会. 中国痔病诊疗指南(2020) [J]. 结直肠肛门外科, 2020, 26(5): 519-533.
|
[3]
|
李玉山. 地奥司明药理作用及临床应用研究进展[J]. 海峡药学, 2015, 27(12): 81-85.
|
[4]
|
Zheng, Y., Zhang, R., Shi, W., et al. (2020) Metabolism and Pharmacolog-ical Activities of the Natural Health-Benefiting Compound Diosmin. Food & Function, 11, 8472-8492. https://doi.org/10.1039/D0FO01598A
|
[5]
|
Li, C. and Schluesener, H. (2017) Health-Promoting Effects of the Cit-rus Flavanone Hesperidin. Critical Reviews in Food Science and Nutrition, 57, 613-631. https://doi.org/10.1080/10408398.2014.906382
|
[6]
|
Garner, R.C., Garner, J.V., Gregory, S., et al. (2002) Com-parison of the Absorption of Micronized (Daflon 500 mg) and Nonmicronized 14C-Diosmin Tablets after Oral Admin-istration to Healthy Volunteers by Accelerator Mass Spectrometry and Liquid Scintillation Counting. Journal of Phar-maceutical Sciences, 91, 32-40.
https://doi.org/10.1002/jps.1168
|
[7]
|
Adouani, I., Qureshi, A.S. and Hang, T.J. (2020) Preparation, Evaluation and Pharmacokinetics of Diosmin Herbosome in Beagle Dogs. Pakistan Journal of Pharmaceutical Sciences, 33, 33-40.
|
[8]
|
王陈翔, 黄爱芳, 金辉, 等. 地奥司明栓剂的制备及质量控制研究[J]. 药学实践杂志, 2017, 35(4): 325-327+349.
|
[9]
|
Tajana, A., Boccasanta, P., Micheletto, G., et al. (1988) Results of the Use of Topical Diosmin (Venosmine) in the Treatment of Acute Hemorrhoid Pathology. Minerva Medica, 79, 387-390.
|
[10]
|
Allaert, F.A. (2012) Meta-Analysis of the Impact of the Principal Venoactive Drugs Agents on Malleolar Venous Edema. International Angi-ology, 31, 310-315.
|
[11]
|
Paysant, J., Sansilvestrimorel, P., Bouskela, E., et al.(2008) Different Flavonoids Present in the Micronized Purified Flavonoid Fraction (Daflon 500 mg) Contribute to Its Anti-Hyperpermeability Effect in the Hamster Cheek Pouch Microcirculation. International Angiology: A Journal of the International Union of Angiology, 27, 81.
|
[12]
|
Cazaubon, M., Benigni, J.P., Steinbruch, M., et al. (2021) Is There a Difference in the Clinical Efficacy of Di-osmin and Micronized Purified Flavonoid Fraction for the Treatment of Chronic Venous Disorders? Review of Available Evidence. Vascular Health and Risk Management, 17, 591-600. https://doi.org/10.2147/VHRM.S324112
|
[13]
|
Meyer, O.C. (1994) Safety and Security of Daflon 500 mg in Ve-nous Insufficiency and in Hemorrhoidal Disease. Angiology, 45, 579-584. https://doi.org/10.1177/000331979404500614
|
[14]
|
Bogucka-Kocka, A., Woźniak, M., Feldo, M., et al. (2013) Di-osmin—Isolation Techniques, Determination in Plant Material and Pharmaceutical Formulations, and Clinical Use. Natu-ral Product Communications, 8, 545-550.
https://doi.org/10.1177/1934578X1300800435
|
[15]
|
Murota, K., Nakamura, Y. and Uehara, M. (2018) Flavonoid Metabolism: The Interaction of Metabolites and Gut Microbiota. Bioscience, Biotechnology, and Biochemistry, 82, 600-610. https://doi.org/10.1080/09168451.2018.1444467
|
[16]
|
曾晓丽, 谢燕, 袁秀荣. 黄酮类化合物体内过程的研究进展[J]. 中国新药杂志, 2010, 19(9): 750-754.
|
[17]
|
Gerges, S.H., Wahdan, S.A., Elsherbiny, D.A., et al. (2021) Pharmacology of Diosmin, a Citrus Flavone Glycoside: An Updated Review. European Journal of Drug Metab-olism and Pharmacokinetics, 47, 1-18.
https://doi.org/10.1007/s13318-021-00731-y
|
[18]
|
Talibov, O.B. (2019) Diosmin in the Treatment of Venous Dis-ease: Pharmacokinetics and Pharmacodynamics (In Russian Only]. Khirurgiia (Mosk), 135-140. https://doi.org/10.17116/hirurgia2019031135
|
[19]
|
Silvestro, L., Tarcomnicu, I., Dulea, C., et al. (2013) Confirma-tion of Diosmetin 3-O-Glucuronide as Major Metabolite of Diosmin in Humans, Using Mi-cro-Liquid-Chromatography-Mass Spectrometry and Ion Mobility Mass Spectrometry. Analytical and Bioanalytical Chemistry, 405, 8295-8310. https://doi.org/10.1007/s00216-013-7237-y
|
[20]
|
Manach, C., Morand, C., Gil-Izquierdo, A., et al. (2003) Bioavailability in Humans of the Flavanones Hesperidin and Narirutin after the Ingestion of Two Doses of Orange Juice. European Journal of Clinical Nutrition, 57, 235-242.
https://doi.org/10.1038/sj.ejcn.1601547
|
[21]
|
Matsumoto, H., Ikoma, Y., Sugiura, M., et al. (2004) Identification and Quantification of the Conjugated Metabolites Derived from Orally Administered Hesperidin in Rat Plasma. Journal of Agricultural and Food Chemistry, 52, 6653-6659.
https://doi.org/10.1021/jf0491411
|
[22]
|
Nectoux, A.M., Abe, C., Huang, S.W., et al. (2019) Absorption and Meta-bolic Behavior of Hesperidin (Rutinosylated Hesperetin) after Single Oral Administration to Sprague-Dawley Rats. Journal of Agricultural and Food Chemistry, 67, 9812-9819. https://doi.org/10.1021/acs.jafc.9b03594
|
[23]
|
Spanakis, M., Kasmas, S. and Niopas, I. (2009) Simultaneous De-termination of the Flavonoid Aglycones Diosmetin and Hesperetin in Human Plasma and Urine by a Validated GC/MS Method: In Vivo Metabolic Reduction of Diosmetin to Hesperetin. Biomedical Chromatography, 23, 124-131. https://doi.org/10.1002/bmc.1092
|
[24]
|
Mandal, P., Dan, S., Chakraborty, S., et al. (2019) Simultaneous Determina-tion and Quantitation of Diosmetin and Hesperetin in Human Plasma by Liquid Chromatographic Mass Spectrometry with an Application to Pharmacokinetic Studies. Journal of Chromatographic Science, 57, 451-461. https://doi.org/10.1093/chromsci/bmz015
|
[25]
|
朱婷婷, 杜明荦, 苏浩明, 等. 地奥司明片在健康人体内的药动学[J]. 中国新药杂志, 2014, 23(14): 1674-1678.
|
[26]
|
Bedada, S.K. and Neerati, P. (2018) Modulation of CYP3A En-zyme Activity by Diosmin and Its Consequence on Carbamazepine Pharmacokinetics in Rats. Naunyn-Schmiedeberg’s Archives of Pharmacology, 391, 115-121.
https://doi.org/10.1007/s00210-017-1439-3
|
[27]
|
Bedada, S.K. and Boga, P.K. (2017) Influence of Diosmin on the Metabolism and Disposition of Carbamazepine in Healthy Subjects. Xenobiotica, 47, 879-884. https://doi.org/10.1080/00498254.2016.1244368
|
[28]
|
Rajnarayana, K., Venkatesham, A., Nagulu, M., et al. (2008) Influence of Diosmin Pretreatment on the Pharmacokinetics of Chlorzoxazone in Healthy Male Volunteers. Drug Metab-olism and Drug Interactions, 23, 311-321.
https://doi.org/10.1515/DMDI.2008.23.3-4.311
|
[29]
|
Rajnarayana, K., Venkatesham, A. and Krishna, D.R. (2007) Bioavailability of Diclofenac Sodium after Pretreatment with Diosmin in Healthy Volunteers. Drug Metabolism and Drug Interactions, 22, 165-174.
https://doi.org/10.1515/DMDI.2007.22.2-3.165
|
[30]
|
Bedada, S.K., Boga, P.K. and Kotakonda, H.K. (2017) The Effect of Diosmin on the Pharmacokinetics of Fexofenadine in Healthy Human Volunteers. Xenobiotica, 47, 230-235. https://doi.org/10.1080/00498254.2016.1180564
|
[31]
|
Neerati, P. and Bedada, S.K. (2015) Effect of Diosmin on the Intestinal Absorption and Pharmacokinetics of Fexofenadine in Rats. Pharmacological Reports, 67, 339-344. https://doi.org/10.1016/j.pharep.2014.09.010
|
[32]
|
Amato, C. (1994) Advantage of a Micronized Flavonoidic Frac-tion (Daflon 500 mg) in Comparison with a Nonmicronizeddiosmin. Angiology, 45, 531-536.
|
[33]
|
于航, 郑瑞芳, 苏文灵, 等. 基于肠道菌的黄酮类成分代谢特征及药理学思考[J]. 药学学报, 2021, 56(7): 1757-1768+1748.
|